Bethany Helm, PA
Physician Assistant · Tamuning, GUNPI 1235605999
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations.
Across 111 payments — averaging $28.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$667
- Teva Pharmaceuticals USA, Inc.$524
- Otsuka America Pharmaceutical, Inc.$444
- Alkermes, Inc.$341
- Lundbeck LLC$288
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$261
- plus $684 from 10 others
What the payments were for
- Food & beverage$3,10397%
- Education$1063%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 16 | $667 |
| Teva Pharmaceuticals USA, Inc. | 14 | $524 |
| Otsuka America Pharmaceutical, Inc. | 18 | $444 |
| Alkermes, Inc. | 11 | $341 |
| Lundbeck LLC | 15 | $288 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $261 |
| Idorsia Pharmaceuticals US Inc | 10 | $222 |
| Vanda Pharmaceuticals Inc. | 4 | $126 |
| AbbVie | 4 | $102 |
| Indivior Inc. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Tempus AI, Inc | 2 | $45 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Johnson & Johnson | 1 | $25 |
| Braeburn Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$498
- INGREZZA$371
- CAPLYTA$126
- ARISTADA INITIO$124
- AUSTEDO$123
- ABILIFY ASIMTUFII$122
- ABILIFY MAINTENA$122
- Austedo XR$121
How this compares
Too few physician assistant providers in Guamto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine ErLamotrigine | 23 | $1,482 |
| Quetiapine Fumarate | 11 | $731 |
| Aripiprazole | 12 | $407 |
| Escitalopram Oxalate | 17 | $159 |
| Bupropion XlBupropion Hcl | 16 | $156 |
| Fluoxetine Hcl | 16 | $118 |
| Lamotrigine | 15 | $105 |
| Mirtazapine | 12 | $93 |
| Sertraline Hcl | 15 | $50 |
| Clonidine Hcl | 14 | $43 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Tamuning
- Walter StrattonTamuning$22
- Caressa KasperbauerTamuning$0
- Khampho OhnoTamuning$0
- David HongTamuning$0
- Karyn KaufmanTamuning$0
- Helene TuncapTamuning$0
- Kamille WangTamuning$0
- Karla WangTamuning$0
- Tina HeinrichTamuning$0
- William StanleyTamuning$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.